|
|
|
|
|
|
|
|
|
|
Previous: NURESCELL INC, 10KSB, EX-12, 2000-07-12 |
Next: WARBURG DILLON READ LLC, 13F-HR/A, 2000-07-11 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED
MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> MAR-31-2000
<PERIOD-START> APR-01-1999
<PERIOD-END> MAR-31-2000
<CASH> 26,945
<SECURITIES> 0
<RECEIVABLES> 8,700
<ALLOWANCES> 0
<INVENTORY> 25,078
<CURRENT-ASSETS> 74,455
<PP&E> 62,958
<DEPRECIATION> 14,021
<TOTAL-ASSETS> 478,385
<CURRENT-LIABILITIES> 338,748
<BONDS> 0
0
0
<COMMON> 1,519
<OTHER-SE> (631,882)
<TOTAL-LIABILITY-AND-EQUITY> 478,385
<SALES> 8,700
<TOTAL-REVENUES> 8,700
<CGS> 21,377
<TOTAL-COSTS> 3,953,931
<OTHER-EXPENSES> 6,778
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 12,709
<INCOME-PRETAX> (3,986,095)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,986,095)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,986,095)
<EPS-BASIC> (0.29)
<EPS-DILUTED> (0.29)
</TABLE>
|
|